Great Point Partners as of Dec. 31, 2014
Portfolio Holdings for Great Point Partners
Great Point Partners holds 28 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Connecture | 23.9 | $50M | 5.5M | 9.01 | |
| Hyperion Therapeutics | 11.5 | $24M | 998k | 24.00 | |
| Alimera Sciences | 7.0 | $15M | 2.6M | 5.54 | |
| Ocera Therapeutics | 6.0 | $13M | 2.0M | 6.37 | |
| Derma Sciences Com Par $.01 | 5.3 | $11M | 1.2M | 9.31 | |
| Infinity Pharmaceuticals (INFIQ) | 5.1 | $11M | 625k | 16.89 | |
| Endologix | 4.8 | $9.9M | 650k | 15.29 | |
| Aurinia Pharmaceuticals (AUPH) | 4.3 | $8.9M | 2.5M | 3.57 | |
| Arrowhead Resh Corp Com New | 4.0 | $8.3M | 1.1M | 7.38 | |
| Aradigm Corp Com No Par New | 3.7 | $7.6M | 1.0M | 7.60 | |
| Emergent BioSolutions (EBS) | 3.3 | $6.8M | 250k | 27.23 | |
| Vericel (VCEL) | 3.2 | $6.6M | 2.2M | 3.04 | |
| Synthetic Biologics | 2.8 | $5.8M | 4.0M | 1.46 | |
| Veracyte (VCYT) | 2.6 | $5.4M | 554k | 9.66 | |
| Tenax Therapeutics | 2.0 | $4.3M | 1.1M | 3.84 | |
| Agenus Com New (AGEN) | 1.8 | $3.7M | 920k | 3.97 | |
| Orthofix International Nv Com Stk | 1.6 | $3.3M | 110k | 30.06 | |
| Exelixis (EXEL) | 1.5 | $3.2M | 2.2M | 1.44 | |
| Adamas Pharmaceuticals | 1.4 | $3.0M | 171k | 17.37 | |
| Vical Incorporated | 1.1 | $2.2M | 2.1M | 1.05 | |
| Onconova Therapeutics | 0.9 | $1.8M | 553k | 3.29 | |
| Bellicum Pharma | 0.6 | $1.2M | 50k | 23.04 | |
| Neurocrine Biosciences Put Option (NBIX) | 0.5 | $1.0M | 46k | 22.34 | |
| Mei Pharma Com New | 0.3 | $673k | 158k | 4.27 | |
| Streamline Health Solutions (STRM) | 0.3 | $656k | 152k | 4.33 | |
| Zogenix | 0.2 | $503k | 368k | 1.37 | |
| Anthera Pharmaceuticals Com New | 0.2 | $395k | 250k | 1.58 | |
| Protalix BioTherapeutics | 0.2 | $392k | 213k | 1.84 |
